Enhancing Comprehensive Assessments in Chronic Heart Failure Caused by Ischemic Heart Disease: The Diagnostic Utility of Holter ECG Parameters

被引:1
|
作者
Duca, Stefania-Teodora [1 ,2 ]
Tudorancea, Ionut [2 ,3 ]
Haba, Mihai Stefan Cristian [1 ,2 ]
Costache, Alexandru-Dan [1 ,4 ]
Serban, Ionela-Lacramioara [3 ]
Paval, D. Robert [5 ]
Loghin, Catalin [6 ]
Costache-Enache, Irina-Iuliana [1 ,2 ]
机构
[1] Univ Med & Pharm Grigore T Popa, Fac Med, Dept Internal Med 1, Iasi 700115, Romania
[2] St Spiridon Emergency Cty Hosp, Dept Cardiol, Iasi 700111, Romania
[3] Univ Med & Pharm Grigore T Popa, Dept Morpho Funct Sci Physiol 2, Iasi 700115, Romania
[4] Clin Rehabil Hosp, Dept Cardiovasc Rehabil, Iasi 700661, Romania
[5] Univ Stirling, Fac Hlth Sci & Sport, Stirling FK9 4LA, Scotland
[6] Univ Texas, Dept Internal Med, Cardiol Div, Hlth Sci Ctr, Houston, TX 77030 USA
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 08期
关键词
ischemic heart disease; chronic heart failure; 24 h Holter ECG; SUDDEN CARDIAC DEATH; T-WAVE ALTERNANS; CORONARY-ARTERY-DISEASE; RATE-VARIABILITY; 24-HOUR HOLTER; DECELERATION CAPACITY; RATE TURBULENCE; RISK; ELECTROCARDIOGRAM; MORTALITY;
D O I
10.3390/medicina60081315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Chronic heart failure (CHF) caused by ischemic heart disease (IHD) is the leading cause of death worldwide and presents significant health challenges. Effective management of IHD requires prevention, early detection, and treatment to improve patient outcomes. This study aims to expand the diagnostic utility of various 24 h Holter ECG parameters, such as T-wave alternans (TWA), late ventricular potentials (LVPs), and heart rate variability (HRV) in patients with CHF caused by IHD. Additionally, we seek to explore the association between these parameters and other comorbid conditions affecting the prognosis of CHF patients. Materials and Methods: We conducted a prospective case-control study with 150 patients divided into two subgroups: 100 patients with CHF caused by IHD, and 50 patients in the control group. Data included medical history, physical examination, laboratory tests, echocardiography, and 24 h Holter monitoring. Results: Our comparative analysis demonstrated that both TWA and LVPs were significantly higher in patients with CHF compared to the control group (p < 0.01), indicating increased myocardial electrical vulnerability in CHF patients. Both time and frequency-domain HRV parameters were significantly lower in the CHF group. However, the ratio of NN50 to the total count of NN intervals (PNN50) showed a borderline significance (p = 0.06). While the low-frequency (LF) domain was significantly lower in CHF patients, the high-frequency (HF) domain did not differ significantly between groups. Acceleration and deceleration capacities were also significantly altered in CHF patients. Categorizing CHF patients by left ventricular ejection fraction (LVEF) revealed that the mean of the 5-min normal-to-normal intervals over the complete recording (SDNN Index) was significantly higher in patients with LVEF >= 50% compared to those with CHF with reduced EF and CHF with mildly reduced EF (p < 0.001), whereas the other HRV parameters showed no significant differences among the groups. Conclusions: Holter ECG parameters can become a reliable tool in the assessment of patients with CHF. The integration of multiple Holter ECG parameters, such as TWA, LVPs, and HRV, can significantly enhance the diagnostic assessment of CHF caused by IHD. This comprehensive approach allows for a more nuanced understanding of the patient's condition and potential outcomes.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease
    Fedorova, TA
    Ilyina, YV
    Sotnikova, TI
    Rybakova, MK
    Loschits, NV
    TERAPEVTICHESKII ARKHIV, 2004, 76 (03) : 62 - 68
  • [42] Diagnostic value of growth differentiation factor-15 and β2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function
    Zhou, X-J
    Zhang, X.
    Zhang, J.
    Zhou, L.
    Zhou, T-T
    Zhang, J-W
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8096 - 8103
  • [43] Effect of Carvedilol and Metoprolol CR Administered With or Without Atorvastatin on Elastic Properties of Vascular Wall and Parameters of Inflammation in Patients With Chronic Heart Failure of Ischemic Origin
    Ozova, E. M.
    Kiyakbaev, G. K.
    Kobalava, Zh. D.
    Moiseev, V. S.
    KARDIOLOGIYA, 2011, 51 (04) : 39 - 46
  • [44] Using routine data for quality of care assessments: A critical review, taking quality indicators for the "National Disease Management Guideline for Chronic Heart Failure'' as an example
    Laux, Gunter
    Nothacker, Monika
    Weinbrenner, Susanne
    Stoerk, Stefan
    Blozik, Eva
    Peters-Klimm, Frank
    Szecsenyi, Juergen
    Scherer, Martin
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2011, 105 (01): : 21 - 26
  • [45] Association of objectively measured daily physical activity and health utility to disease severity in chronic heart failure patients: A cross-sectional study
    Izawa, Kazuhiro P.
    Kasahara, Yusuke
    Watanabe, Satoshi
    Oka, Koichiro
    Brubaker, Peter H.
    Kida, Keisuke
    Akashi, Yoshihiro J.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2021, 10
  • [46] Predicting the outcome of heart failure against chronic-ischemic heart disease in elderly population-Machine learning approach based on logistic regression, case to Villa Scassi hospital Genoa, Italy
    Stojanov, Done
    Lazarova, Elena
    Veljkova, Elena
    Rubartelli, Paolo
    Giacomini, Mauro
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (03)
  • [47] Comprehensive care for people living with heart failure and chronic obstructive pulmonary disease-Integration of palliative care with disease-specific care: From guidelines to practice
    Kowalczys, Anna
    Bohdan, Michal
    Wilkowska, Alina
    Pawlowska, Iga
    Pawlowski, Leszek
    Janowiak, Piotr
    Jassem, Ewa
    Lelonek, Malgorzata
    Gruchala, Marcin
    Sobanski, Piotr
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] Comprehensive rehabilitation in chronic heart failure -: Better psycho-emotional status related to quality of life, brain natriuretic peptide concentrations, and clinical severity of disease
    Laederach-Hofmann, Kurt
    Rohrer-Guebeli, Rebecca
    Messerli, Nadine
    Meyer, Katharina
    CLINICAL AND INVESTIGATIVE MEDICINE, 2007, 30 (02): : E54 - E62
  • [49] The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis
    Ma, Hongzhen
    Zhou, Jun
    Zhang, Meng
    Shen, Chun
    Jiang, Zhifan
    Zhang, Tao
    Gao, Fei
    MEDICAL SCIENCE MONITOR, 2023, 29
  • [50] A comprehensive review of heart failure: Unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction
    Elendu, Chukwuka
    Amaechi, Dependable C.
    Elendu, Tochi C.
    Fiemotonghan, Border-ere
    Okoye, Osinachi K.
    Agu-Ben, Chigozirim M.
    Onyekweli, Samuel O.
    Amapu, Dorcas A.
    Ikpegbu, Richard
    Asekhauno, Mercy
    Pius, Erica
    Bayo-Shodipo, Adediwura T.
    Okezie-Okoye, Chidera A.
    Bello, Nurudeen
    Oguine, Chibuike
    Edochie, Promise
    Dike, Nkechinyere
    Amos, Ibirongbe
    Asekhauno, Joan
    Wusu-Ejalonibu, Tanitoluwa M.
    Ozigi, Emmanuella E.
    Otobo, Grace O.
    Olokodana, Aderinsola R.
    Ayabazu, Chiagozie P.
    Nwafor, Raphael T.
    Gonji, Nandir J.
    Akpovona, Otite
    Awotoye, Temitope I.
    Ozigis, Mutalib O.
    Afolabi, Oluwatosin
    Alabi, Omotayo S.
    Adebayo, Mololuwa
    MEDICINE, 2024, 103 (03) : E36895